3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Mucositis
17
Pain
12
Opioid-Induced Constipation
12
Constipation
12
Obesity
11
Sexual Dysfunction, Physiological
9
Head and Neck Neoplasms
8
Neoplasms
7
Breast Neoplasms
7
Polycystic Ovary Syndrome
4
Bronchiolitis Obliterans Syndrome
4
Weight Loss
3
Prostatic Neoplasms
3
Intestinal Diseases
3
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Sexuality
2
Prediabetic State
2
Intestinal Obstruction
2
Hyperinsulinism
2
Fatigue
2
Dyspnea
2
Xerostomia
1
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Interventions
Liraglutide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Glucose Intolerance
×
Other
×
Clear all
NCT03480022
2021-06-07
SAXAPCOS
Woman's
Phase 3
Completed
88 enrolled
35 charts